Appleton Partners Inc. MA increased its position in shares of Xylem Inc (NYSE:XYL) by 11.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,181 shares of the industrial products company’s stock after acquiring an additional 3,380 shares during the period. Appleton Partners Inc. MA’s holdings in Xylem were worth $2,263,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of XYL. Invictus RG acquired a new stake in shares of Xylem during the 3rd quarter worth about $104,000. Harfst & Associates Inc. raised its position in shares of Xylem by 26.1% during the 2nd quarter. Harfst & Associates Inc. now owns 2,433 shares of the industrial products company’s stock worth $134,000 after acquiring an additional 503 shares in the last quarter. Tower Research Capital LLC TRC acquired a new stake in shares of Xylem during the 2nd quarter worth about $168,000. FNY Partners Fund LP raised its position in shares of Xylem by 2,700.0% during the 3rd quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after acquiring an additional 2,700 shares in the last quarter. Finally, Federated Investors Inc. PA raised its position in shares of Xylem by 5.8% during the 2nd quarter. Federated Investors Inc. PA now owns 3,286 shares of the industrial products company’s stock worth $182,000 after acquiring an additional 181 shares in the last quarter. 85.55% of the stock is currently owned by hedge funds and other institutional investors.
In other Xylem news, Director Steven R. Loranger sold 17,139 shares of the business’s stock in a transaction dated Wednesday, December 20th. The stock was sold at an average price of $68.10, for a total transaction of $1,167,165.90. Following the completion of the sale, the director now owns 26,150 shares of the company’s stock, valued at $1,780,815. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Tomas Brannemo sold 2,260 shares of the business’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $67.75, for a total value of $153,115.00. Following the sale, the insider now directly owns 10,975 shares of the company’s stock, valued at approximately $743,556.25. The disclosure for this sale can be found here. In the last three months, insiders have sold 112,707 shares of company stock valued at $7,592,370. 0.75% of the stock is owned by company insiders.
Xylem Inc (NYSE XYL) traded up $0.82 during midday trading on Friday, hitting $75.66. The stock had a trading volume of 2,138,393 shares, compared to its average volume of 813,472. Xylem Inc has a 12 month low of $46.67 and a 12 month high of $76.81. The firm has a market capitalization of $13,590.00, a PE ratio of 41.34, a price-to-earnings-growth ratio of 1.74 and a beta of 1.20. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.26 and a current ratio of 1.88.
Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.76. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The business’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.66 earnings per share. analysts forecast that Xylem Inc will post 2.87 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Thursday, February 15th will be given a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.11%. This is an increase from Xylem’s previous quarterly dividend of $0.18. Xylem’s payout ratio is currently 39.34%.
XYL has been the topic of a number of research reports. Canaccord Genuity restated a “hold” rating and set a $56.00 price target on shares of Xylem in a research note on Friday, October 6th. Stifel Nicolaus reiterated a “hold” rating and issued a $63.00 target price on shares of Xylem in a research note on Friday, October 13th. Oppenheimer reiterated a “buy” rating on shares of Xylem in a research note on Tuesday, October 31st. Boenning Scattergood reiterated a “buy” rating on shares of Xylem in a research note on Friday, December 15th. Finally, Zacks Investment Research cut Xylem from a “buy” rating to a “hold” rating in a report on Wednesday, December 6th. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Xylem presently has a consensus rating of “Buy” and an average price target of $70.00.
ILLEGAL ACTIVITY NOTICE: “Xylem Inc (XYL) Position Lifted by Appleton Partners Inc. MA” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/04/xylem-inc-xyl-shares-bought-by-appleton-partners-inc-ma.html.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.